Go Pro

NOVONIX (NVX) Projected to Announce Earnings on Thursday

NOVONIX logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • NOVONIX is expected to report its H1 2026 results on August 20, 2026. Analysts project a loss of $0.2464 per share and revenue of approximately $33.0 million.
  • NOVONIX shares opened at $0.43, near their 12-month low of $0.37 and well below the 12-month high of $3.86. The stock has an average analyst rating of “Sell.”
  • Institutional ownership remains limited at 0.06%, although several investors recently initiated or increased positions, including Virtu Financial and Bank of America.
  • Interested in NOVONIX? Here are five stocks we like better.

NOVONIX (NASDAQ:NVX - Get Free Report) is anticipated to release its H1 2026 resultson Thursday, August 20th. Analysts expect NOVONIX to announce earnings of ($0.2464) per share and revenue of $33.0030 million for the quarter. Interested persons can find conference call details on the company's upcoming H1 2026 earning overview page for the latest details on the call scheduled for Thursday, August 20, 2026 at 8:00 PM ET.

NOVONIX Stock Performance

NASDAQ NVX opened at $0.43 on Thursday. The company has a fifty day simple moving average of $0.47 and a 200 day simple moving average of $0.68. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.07 and a quick ratio of 1.04. NOVONIX has a 12-month low of $0.37 and a 12-month high of $3.86.

Analyst Ratings Changes

Separately, Weiss Ratings upgraded shares of NOVONIX from a "sell (e+)" rating to a "sell (d-)" rating in a report on Friday, July 31st. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has an average rating of "Sell".

View Our Latest Stock Report on NOVONIX

Hedge Funds Weigh In On NOVONIX

Several large investors have recently bought and sold shares of the stock. OLD Mission Capital LLC bought a new stake in shares of NOVONIX in the 4th quarter worth $32,000. Susquehanna International Group LLP bought a new position in shares of NOVONIX during the third quarter valued at about $65,000. Virtu Financial LLC boosted its holdings in NOVONIX by 316.5% during the fourth quarter. Virtu Financial LLC now owns 76,137 shares of the company's stock worth $77,000 after purchasing an additional 57,859 shares during the last quarter. Bank of America Corp DE boosted its holdings in NOVONIX by 335.1% during the third quarter. Bank of America Corp DE now owns 72,972 shares of the company's stock worth $93,000 after purchasing an additional 56,200 shares during the last quarter. Finally, Quadrature Capital Ltd bought a new stake in NOVONIX in the 4th quarter worth about $97,000. 0.06% of the stock is currently owned by institutional investors.

About NOVONIX

(Get Free Report)

NOVONIX, trading under the NASDAQ ticker NVX, is a technology-driven company specializing in the development and production of advanced materials and testing solutions for the lithium-ion battery industry. The company's primary focus lies in supplying high-purity synthetic graphite anode materials and delivering comprehensive battery testing services to original equipment manufacturers (OEMs), research institutions, and battery producers worldwide. NOVONIX operates through two core divisions: NOVONIX Materials & Technology, which produces battery-grade graphite, and NOVONIX Battery Testing Solutions, which offers hardware and software platforms designed to accelerate battery research and development.

The Materials & Technology business segment manufactures spherical synthetic graphite anode products that meet rigorous industry standards for performance, consistency, and scalability.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in NOVONIX Right Now?

Before you consider NOVONIX, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NOVONIX wasn't on the list.

While NOVONIX currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines